More importantly, antibody-mediated depletion of total CD4 T cells reduced the amounts of hepatic inflammatory cytokines, NAFLD activity score, and fibrosis in these humanized NASH mice, suggesting that disease development is a CD4 T cell-dependent process (64). Here, CD4 is linked to metabolic dysfunction-associated steatohepatitis.